Audience: Pharmacy students, Pharmacy Residents, Nurse Practitioners, Nurse Practitioner Students, Physician Assistants, and primary care physicians Each chapter uses a standardized approach to therapeutic decision making: systematic review of the literature, specific recommendations, treatment algorithms to facilitate decision-making, and evidence-based summaries Treatment algorithms facilitate decision-making
The only pharmacology resource specifically written by and for nurse practitioners, this new edition provides a greater emphasis on prototype drugs while retaining its comprehensive approach to the pharmacology content needed by the primary care provider. New features include prototype drug lists in the coverage of drug classes that receive expanded coverage, detailed patient teaching guidelines, expanded content in both the geriatric and pediatric chapters, a special icon identifying the Top 200 Drugs, and highlighted Clinical Alerts. Comprehensive coverage is provided of all drugs commonly prescribed and used in the primary care setting. Prototype drugs are presented first in each drug class, with expanded coverage of these agents. Clear explanations describe how each drug in a class differs from its prototype. Detailed information shows how to provide effective patient teaching, as well as how to gain patient compliance. Chapters focus on the practitioner's role in patient teaching, drug action, and drug therapy. Online Resources are provided at the end of each chapter. The Top 200 Drugs are described according to the number of U.S. prescriptions dispensed. Five new units improve the organization of material: Renal/Genitourinary Agents (Unit 8); Psychotropic Agents (Unit 11); Endocrine Agents (Unit 12); Female Reproductive Agents (Unit 13); and Health Promotion (Unit 15). New chapters examine over-the-counter medications, compliance and the therapeutic experiment, overview of the nervous system, substance abuse, treatment of common infections, weight management, and complementary and alternative treatments. Reorganized and redesigned format and headings are more consistent and easy to follow. Content has been expanded in the geriatric and pediatric "special populations" chapters (Ch. 6 and 7). More concise coverage of disease processes features clearer ties to the Mechanism of Action sections. 25 new figures have been added to the pathophysiology and Mechanisms of Action sections. A Table of Common Interactions is included on the inside of the back cover.
Delivers the critical information primary care providers need to be thoroughly informed prescribers This unique resource—an evidence-based pharmacology text and reference for advanced practice students and clinicians—guides users in analyzing the pharmacological foundations of drug therapy and fosters the development of sound clinical judgment in determining the appropriate medication for every patient across the lifespan. Targeting the specific needs of APRN and PA students and clinicians, the text is a “bridge” between standard, lengthy pharmacology texts and quick pocket references that lack information regarding key pharmacotherapy principles. Featuring an applied therapeutic approach to major disorders and their pharmacologic treatment, the book examines how medications act on the body and visa versa, while teaching the rationale for using specific therapeutic agents or drug classes. Each chapter includes case studies that apply the concepts discussed, relevant diagnostic studies, applicable guidelines, genomics, and important lifespan considerations. Of special interest is a chapter on pharmacogenetics explaining the basic principles underlying our current understanding of genetic variations in response to pharmacotherapy and adverse drug reactions. Easily digestible chapters include objectives and review questions. Ancillary resources include an instructor manual with learning objectives, chapter summaries, and case studies; chapter PowerPoint slides; test bank; and image bank. Key Features: Delivers an applied, evidence-based foundation on the basic science underlying prescribing Targets the specific needs of APRN and PA students and professionals and related healthcare providers Provides clinical decision-making tools and principles to support sound prescribing judgment Focuses on synthesizing drugs to manage commonly occurring disorders Includes strategies for addressing the needs of specific populations throughout the lifespan Includes abundant case studies illuminating key concepts Includes a robust instructor manual with learning objectives, chapter summaries, and case studies; PowerPoint slides; test bank; and image bank. Purchase includes access to the eBook for use on most mobile devices or computers.
An innovative psychiatry textbook that presents behavioral disorders from the perspective of what is seen in medical settings The goal of Essentials of Psychiatry in Primary Care is not to make psychiatrists out of medical clinicians, but rather, to help clinicians manage common behavioral conditions that most often present in a medical setting. Essentials of Psychiatry in Primary Care seeks to integrate medicine and psychiatry --- as the authors’ systems-based biopsychosocial model proposes. The book identifies physical symptoms as a common mode of presentation of mental health problems and describes how to integrate them with psychological symptoms to make diagnoses of mental disorders. Essentials of Psychiatry in Primary Care also details a behaviorally defined, evidence-based mental healthcare model that can be effectively used in a medical setting. The combined experiences in primary care of the authors --- who specialize in both general internal medicine and psychiatry --- provide the perfect background for a book of this nature. Having trained medical students, as well as internal and family medicine residents since 1986, their experience and research demonstrates the information they outline is effective and associated with improved mental and physical health outcomes.
Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.
With its strong practical orientation, this book is a must-read for psychologists who have or want to obtain prescriptive authority, as well as those who wish to assume more collaborative roles within primary care and other settings."--pub. desc.
New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attemptâ€"with or without medical assistanceâ€"to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.
Pharmacists now have a new resource to help expand their HIV knowledge, guide their treatment, and provide comprehensive care. This book is the first of its kind to provide pharmacists with a consolidated resource for offering care to patients with HIV infection, including diagnosis, primary care, pharmacological management of co-infections, and more.
Neurocritical Care Pharmacotherapy: A Clinican's Guide is a practical, succinct but comprehensive pharmacy handbook provides up-to-date clinical guidance on the effective selection, prescription, and usage of neurocritical care drugs for patients with acute neurologic illnesses. The treatment of the critically ill neurologic patient is often difficult, specialized, and includes drugs infrequently used in other intensive care units such as antiepileptic drugs, osmotic agents or acute immunotherapy such as intravenous immunoglobulin and plasma exchange. This text discusses choosing the right combination of drugs; how to correctly prescribe and administer the drugs; how to monitor drug efficacy and side effects; how neurocritical care drugs interact with other medications; and comprehensive coverage of current treatment options. Key Feature of this Manual Include - A brief discussion of the basic pharmacology of each neurocritical drug, with an emphasis on how to select and use these drugs in multiple clinical contexts. - 150 drugs accompanied by a diagram for quick comprehension and drug administration guides. - Unique blending of expertise of neurointensivist with a critical care pharmacist to provide a vital resource for both specialities - References for further reading that are oriented toward utility in clinical practice.
